10.38 USD
↗ 0.32 (3.18%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
10.36
↘ 0.03 (0.24%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
10.36
↘ 0.03 (0.24%)
Market: OPEN
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $10.36 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (122.9%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 25, 2026.
Open?$10.19
High?$10.88
Low?$10.05
Prev. Close?$10.06
Volume?97.6K
Avg. Volume?133.0K
VWAP?$10.54
Rel. Volume?0.73x
Bid / Ask
Bid?$8.64 × 100
Ask?$11.84 × 100
Spread?$3.20
Midpoint?$10.24
Valuation & Ratios
Market Cap?304.4M
Shares Out?30.3M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-2.43
EPS?-$5.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
304.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.41Distress
Confidence?65%Moderate
Short InterestVery High
Short % of Float?15.49%High
Short Interest?1.9M
Days to Cover?17.9
Free Float12.1M
Avg Daily Volume104.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?7.48Strong
Quick Ratio?7.48Strong
Cash Ratio?7.18Strong
Debt/Equity?-0.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-2.43CHEAP▾
S&P97
P/S?206.07HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
S&P97
EV/Sales?141.92HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?122.9%STRONG▾
Peers50
S&P97
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-78612000
Enterprise Value?$209.6M
Fundamentals ratios updated end of day